Eton Pharmaceuticals, Inc. (ETON) Earnings History
Net Loss9 years of earnings data (2017–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Eton Pharmaceuticals, Inc. (ETON) Earnings Overview
As of June 23, 2026, Eton Pharmaceuticals, Inc. (ETON) reported trailing twelve-month net income of -$1M, reflecting -13.3% year-over-year growth. The company earned $-0.05 per diluted share over the past four quarters, with a net profit margin of -5.8%.
Looking at the long-term picture, ETON's historical earnings data spans multiple years. The company achieved its highest annual net income of -$936,000 in fiscal 2023.
Eton Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PRAX (-$327M net income), AVDL (-$278,000 net income, -28.9% margin), TLRY (-$2.95B net income, -266.3% margin), ETON has comparable earnings metrics. Compare ETON vs PRAX →
ETON Earnings vs Peers
Earnings metrics vs comparable public companies
ETON Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$5M | -20.4% | $72,000 | $-0.17 | -5.8% | 0.1% |
| 2024 | -$4M | -308.4% | -$3M | $-0.15 | -9.8% | -6.7% |
| 2023 | $-936,000 | +89.6% | -$1M | $-0.04 | -3.0% | -3.8% |
| 2022 | -$9M | -361.4% | -$8M | $-0.36 | -42.4% | -38.9% |
| 2021 | -$2M | +93.0% | -$1M | $-0.08 | -9.0% | -6.8% |
| 2020 | -$28M | -52.7% | -$27M | $-1.33 | -71717.9% | -69515.4% |
| 2019 | -$18M | -43.8% | -$19M | $-1.02 | -1910.3% | -1939.6% |
| 2018 | -$13M | -78.0% | -$10M | $-1.99 | - | - |
| 2017 | -$7M | - | -$7M | $-0.41 | - | - |
Download Data
Export ETON earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ETON — Frequently Asked Questions
Quick answers to the most common questions about buying ETON stock.
What is ETON earnings per share (EPS)?
ETON trailing twelve-month (TTM) diluted EPS is $-0.05, reflecting -13.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2025 is available in the table on this page.
What is Eton Pharmaceuticals, Inc.'s net income?
Eton Pharmaceuticals, Inc. (ETON) trailing twelve-month net income is $-1M as of 2025. Earnings declined -13.3% year-over-year.
Is ETON profitable?
ETON is not currently profitable on a TTM basis, reporting a net loss of $-1M. Net margin is -5.8%. Investors should monitor for a return to profitability.
What is ETON's earnings growth rate?
ETON compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2025.
What are ETON's profit margins?
Eton Pharmaceuticals, Inc. net profit margin is -5.8%, operating margin is +0.1%, and gross margin is +53.5%. Below-average margins reflect competitive or cost pressures. Return on Equity is -18.2%.
Is ETON growing earnings?
ETON earnings are declining — EPS fell -13.3% year-over-year. TTM net income dropped to $-1M. This contrasts with the 5-year CAGR of N/A.
What was ETON's best earnings year?
Eton Pharmaceuticals, Inc.'s highest annual net income on record is $-936000.00, achieved in fiscal year 2023. Earnings history on this page spans 2017 to 2025 and includes all annual and quarterly figures.
What were ETON's earnings last quarter?
ETON's most recent reported quarter was Q1 2026. Net income was $2M with diluted EPS of $0.05. For a full breakdown of all quarters, see the quarterly earnings table on this page.